We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$53M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$26.7M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$23.7M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$19.5M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KKR icon
2651
KKR & Co
KKR
$103B
$90K ﹤0.01%
2,095
-15,596
-88% -$788K
LEN.B icon
2652
Lennar Class B
LEN.B
$20.7B
$90K ﹤0.01%
1,584
+809
+104% +$49.2K
VMEO
2653
DELISTED
Vimeo
VMEO
$90K ﹤0.01%
22,549
+18,546
+463% +$110K
AIRG icon
2654
Airgain
AIRG
$67.7M
$89K ﹤0.01%
12,387
+1,230
+11% +$9.82K
CCCC icon
2655
C4 Therapeutics
CCCC
$502M
$89K ﹤0.01%
10,100
+7,268
+257% +$75.5K
DCGO icon
2656
DocGo
DCGO
$64.5M
$89K ﹤0.01%
8,946
+1,171
+15% +$10.6K
DH icon
2657
Definitive Healthcare
DH
$68.4M
$89K ﹤0.01%
5,710
+3,943
+223% +$86.7K
MERC icon
2658
Mercer International
MERC
$33.8M
$89K ﹤0.01%
+7,278
New +$108K
PRDO icon
2659
Perdoceo Education
PRDO
$1.99B
$89K ﹤0.01%
8,692
+5,700
+191% +$68.1K
PRLB icon
2660
Protolabs
PRLB
$2.21B
$89K ﹤0.01%
2,454
+906
+59% +$39.3K
PSEC icon
2661
Prospect Capital
PSEC
$1.18B
$89K ﹤0.01%
14,320
-5,489
-28% -$41K
RLJ icon
2662
RLJ Lodging Trust
RLJ
$1.67B
$89K ﹤0.01%
8,857
+3,345
+61% +$40.1K
TECK icon
2663
Teck Resources
TECK
$31.3B
$89K ﹤0.01%
2,925
-926
-24% -$28.6K
USNA icon
2664
Usana Health Sciences
USNA
$252M
$89K ﹤0.01%
1,595
+1,186
+290% +$78.4K
AAMI
2665
Acadian Asset Management
AAMI
$3.31B
$89K ﹤0.01%
5,928
-6,728
-53% -$121K
ACWX icon
2666
iShares MSCI ACWI ex US ETF
ACWX
$12B
$88K ﹤0.01%
+2,192
New +$97.5K
ALXO icon
2667
ALX Oncology
ALXO
$268M
$88K ﹤0.01%
9,200
+2,110
+30% +$24.6K
BROS icon
2668
Dutch Bros
BROS
$8.93B
$88K ﹤0.01%
2,835
+37
+1% +$1.39K
CLPT icon
2669
ClearPoint Neuro
CLPT
$470M
$88K ﹤0.01%
+8,494
New +$112K
CRGY icon
2670
Crescent Energy
CRGY
$3.93B
$88K ﹤0.01%
6,591
+4,577
+227% +$67.1K
CSR
2671
Centerspace
CSR
$939M
$88K ﹤0.01%
1,303
+784
+151% +$62.2K
CVRX icon
2672
CVRx
CVRX
$78.3M
$88K ﹤0.01%
+9,382
New +$74.3K
HGTY icon
2673
Hagerty
HGTY
$1.32B
$88K ﹤0.01%
+9,775
New +$111K
INDI icon
2674
indie Semiconductor
INDI
$875M
$88K ﹤0.01%
12,092
+9,006
+292% +$66.7K
OWL icon
2675
Blue Owl Capital
OWL
$19.7B
$88K ﹤0.01%
9,526
+7,822
+459% +$86.9K
105 106
107
108 109

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.